Liaoning OxiranchemInc Past Earnings Performance
Past criteria checks 0/6
Liaoning OxiranchemInc's earnings have been declining at an average annual rate of -45.3%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 8.6% per year.
Key information
-45.3%
Earnings growth rate
-46.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -8.6% |
| Return on equity | -10.4% |
| Net Margin | -9.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Liaoning OxiranchemInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,632 | -327 | 206 | 52 |
| 31 Dec 23 | 3,813 | -309 | 178 | 54 |
| 30 Sep 23 | 4,254 | -197 | 155 | 54 |
| 30 Jun 23 | 4,760 | -192 | 151 | 53 |
| 31 Mar 23 | 5,237 | -154 | 153 | 55 |
| 01 Jan 23 | 5,639 | 6 | 155 | 56 |
| 30 Sep 22 | 6,103 | 168 | 189 | 56 |
| 30 Jun 22 | 6,520 | 317 | 211 | 55 |
| 31 Mar 22 | 6,675 | 401 | 192 | 52 |
| 01 Jan 22 | 6,717 | 352 | 194 | 50 |
| 30 Sep 21 | 6,785 | 291 | 179 | 49 |
| 30 Jun 21 | 6,470 | 345 | 150 | 49 |
| 31 Mar 21 | 6,336 | 440 | 154 | 50 |
| 31 Dec 20 | 5,708 | 403 | 150 | 47 |
| 30 Sep 20 | 5,719 | 415 | 201 | 46 |
| 30 Jun 20 | 5,758 | 361 | 213 | 44 |
| 31 Mar 20 | 5,697 | 308 | 226 | 39 |
| 31 Dec 19 | 6,389 | 352 | 237 | 38 |
| 30 Sep 19 | 6,410 | 316 | 207 | 34 |
| 30 Jun 19 | 7,098 | 333 | 235 | 24 |
| 31 Mar 19 | 7,667 | 353 | 239 | 26 |
| 31 Dec 18 | 7,449 | 326 | 240 | 29 |
| 30 Sep 18 | 7,421 | 304 | 281 | 23 |
| 30 Jun 18 | 6,655 | 254 | 227 | 51 |
| 31 Mar 18 | 5,895 | 214 | 226 | 41 |
| 31 Dec 17 | 5,699 | 209 | 227 | 29 |
| 30 Sep 17 | 5,254 | 140 | 225 | 28 |
| 30 Jun 17 | 4,945 | 125 | 253 | 0 |
| 31 Mar 17 | 4,596 | 115 | 249 | 0 |
| 31 Dec 16 | 4,347 | 76 | 244 | 0 |
| 30 Sep 16 | 3,831 | -22 | 205 | 0 |
| 30 Jun 16 | 3,415 | -188 | 210 | 0 |
| 31 Mar 16 | 3,157 | -226 | 209 | 0 |
| 31 Dec 15 | 2,965 | -210 | 208 | 0 |
| 30 Sep 15 | 2,804 | -94 | 184 | 0 |
| 30 Jun 15 | 2,777 | 41 | 167 | 0 |
| 31 Mar 15 | 2,845 | 72 | 171 | 0 |
| 31 Dec 14 | 2,883 | 92 | 163 | 0 |
| 30 Sep 14 | 2,932 | 112 | 177 | 0 |
| 30 Jun 14 | 2,829 | 108 | 186 | 0 |
| 31 Mar 14 | 2,642 | 91 | 170 | 0 |
| 31 Dec 13 | 2,494 | 81 | 163 | 0 |
| 30 Sep 13 | 2,371 | 72 | 141 | 0 |
| 30 Jun 13 | 2,146 | 70 | 129 | 0 |
Quality Earnings: 300082 is currently unprofitable.
Growing Profit Margin: 300082 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300082 is unprofitable, and losses have increased over the past 5 years at a rate of 45.3% per year.
Accelerating Growth: Unable to compare 300082's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300082 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.8%).
Return on Equity
High ROE: 300082 has a negative Return on Equity (-10.44%), as it is currently unprofitable.